The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: bevacizumab     Quarter: 2016Q3

Total Drug/Injury Combinations: 786     Number of Pages: 40

DRUGNAME PT EventCount
Bevacizumab Gastrointestinal oedema 2 view events
Bevacizumab Gastrointestinal toxicity 2 view events
Bevacizumab Generalised tonic-clonic seizure 2 view events
Bevacizumab Glomerulosclerosis 2 view events
Bevacizumab Haemorrhagic stroke 2 view events
Bevacizumab Haemothorax 2 view events
Bevacizumab Hepatic enzyme increased 2 view events
BEVACIZUMAB Hyperammonaemia 2 view events
Bevacizumab Hypertriglyceridaemia 2 view events
BEVACIZUMAB Hypophagia 2 view events
BEVACIZUMAB Intraocular pressure increased 2 view events
Bevacizumab Ischaemia 2 view events
BEVACIZUMAB Joint deposit 2 view events
Bevacizumab Klebsiella sepsis 2 view events
Bevacizumab Laboratory test abnormal 2 view events
Bevacizumab Laryngospasm 2 view events
Bevacizumab Lipase abnormal 2 view events
Bevacizumab Liver function test abnormal 2 view events
Bevacizumab Liver injury 2 view events
Bevacizumab Malignant pleural effusion 2 view events

Total Drug/Injury Combinations: 786     Number of Pages: 40

NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)